# A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration

> **NCT02121522** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 14 (actual)

## Conditions studied

- Wet Macular Degeneration

## Interventions

- **DRUG:** BI 144807

## Key facts

- **NCT ID:** NCT02121522
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02121522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02121522, "A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02121522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*